Keiko Imamura

Modeling Alzheimer’s Disease with iPSCs Reveals Stress Phenotypes Associated with Intracellular Aβ and Differential Drug Responsiveness

Takayuki Kondo, Masashi Asai, Kayoko Tsukita et al. · Cell stem cell · 2013 · 741 citations · Full text

Neurodegenerative Diseases, Intracellular Aβ, Alzheimer's Disease +9

The Src/c-Abl pathway is a potential therapeutic target in amyotrophic lateral sclerosis

Keiko Imamura, Yuishin Izumi, Akira Watanabe et al. · Science Translational Medicine · 2017 · 249 citations · Full text

iPSC-Based Compound Screening and In Vitro Trials Identify a Synergistic Anti-amyloid β Combination for Alzheimer’s Disease

Takayuki Kondo, Keiko Imamura, Misato Funayama et al. · Cell Reports · 2017 · 221 citations · Full text

High molecular weight amyloid β _1‐42 oligomers induce neurotoxicity <i>via</i> plasma membrane damage

Taro Yasumoto, Yusaku Takamura, Mayumi Tsuji et al. · The FASEB Journal · 2019 · 103 citations · Full text

D‐β‐hydroxybutyrate protects dopaminergic SH‐SY5Y cells in a rotenone model of Parkinson's disease

Keiko Imamura, Takao Takeshima, Yoshihiro Kashiwaya et al. · Journal of Neuroscience Research · 2006 · 98 citations